プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Shail M.に依頼

United States

PhD, Pharmacology | Cell and Molecular Biology | Medical writing | Clinical Trial

プロフィール概要

Experienced researcher with technical expertise in Oncology, R language, drug, and biomarker discovery

専門分野

• ☆ R
• ☆ Pharmacy
• ☆ Cancer Research

サービス

• Writing
• Writing

Writing Clinical Trial Documentation, Medical Writing, Non-Medical Regulatory Writing, Technical Writing, Copywriting, Creative Writing

職務経験

PhD Candidate

MCPHS University

9月 2019 - 現在

学歴

Doctor of Philosophy (Pharmaceutical Sciences)

MCPHS University

8月 2019 - 4月 2024

Master of Pharmacy (Pharmaceutical Sciences)

University of Mumbai

8月 2014 - 5月 2016

Bachelor of Pharmacy (Pharmaceutical Sciences)

University of Mumbai

8月 2010 - 5月 2014

認定資格

• 認定資格の詳細は未入力です。

出版物

BOOK CHAPTER

Jetha, K.L., Vyas, A., Teli, D., Chaudhari, A., Satasiya, R., Patel, V., Soni, S., Modi, S. and Apostolopoulos, V. (2024). History of Nanoparticles. In Nanocarrier Vaccines (eds V.P. Chavda and V. Apostolopoulos). https://doi.org/10.1002/9781394175482.ch1 .

Andey, T., Soni, S., & Modi, S. (2024). Chapter 3 - Conventional vaccination methods: Inactivated and live attenuated vaccines. In V. P. Chavda, L. K. Vora, & V. Apostolopoulos (Eds.), Advanced Vaccination Technologies for Infectious and Chronic Diseases (pp. 37-50). Academic Press. https://doi.org/https://doi.org/10.1016/B978-0-443-18564-9.00030-8 .

JOURNAL ARTICLE

Shail Rakesh Modi, Terrick Andey, George Acquaah-Mensah. NFE2L3 regulates the expression of BHLHE40 in triple-negative breast cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 4883 .

Shail Modi, Keshava L. Jetha, Arya Vyas, Divya Teli, Amit Chaudhari, Riyansi Satasiya, Vishwa Patel, Shailvi Soni, Vasso Apostolopoulos (2024). History of Nanoparticles . Nanocarrier Vaccines.

Shail Modi, Terrick Andey, Shailvi Soni (2024). Conventional vaccination methods: Inactivated and live attenuated vaccines . Advanced Vaccination Technologies for Infectious and Chronic Diseases.

Shail Modi, Nandini Gandhi, Hoeyoon Yoon, Jeihun Kuack, Hyejoo Jee, Chidinma Enwere, Onel Iskarous, Walaa Farag, George Acquaah-Mensah (2023). Gene expression changes in COVID-19 patients impact pathways related to circadian rhythm, phosphatidylinositol signaling, cytokine storm, and platelet aggregation . Gene Reports.

Modi, S., Gandhi, N., Yoon, H., Kuack, J., Jee, H., Enwere, C., Iskarous, O., Farag, W., & Acquaah-Mensah, G. (2023, 2023/12/01/). Gene expression changes in COVID-19 patients impact pathways related to circadian rhythm, phosphatidylinositol signaling, cytokine storm, and platelet aggregation. Gene Reports, 33, 101831. https://doi.org/https://doi.org/10.1016/j.genrep.2023.101831 .

Modi, Shail, Gandhi, Nandini, Yoon, Hoeyoon, Kuack, Jeihun, Jee, Hyejoo, Enwere, Chidinma, Iskarous, Onel, Farag, Walaa, Acquaah-Mensah, George (2023). Gene expression changes in COVID-19 patients impact pathways related to circadian rhythm, phosphatidylinositol signaling, cytokine storm, and platelet aggregation . Gene Reports.

Modi, S., Gandhi, N., Yoon, H., Kuack, J., Jee, H., Enwere, C., Iskarous, O., Farag, W., Acquaah-Mensah, G.(2023). Gene expression changes in COVID-19 patients impact pathways related to circadian rhythm, phosphatidylinositol signaling, cytokine storm, and platelet aggregation . Gene Reports. 33.

Modi, Shail Rakesh, Andey, Terrick, Acquaah-Mensah, George (2022). The role of master regulators such as HMGA1, SOX9, FOXA1 in the development of triple-negative breast cancer . The FASEB Journal.

Harsha, K., Vasudha, P., & Shail, M. (2019). Cyanoacrylates: An overview in its application as a tissue adhesive.European Journal of pharmaceutical and Medical Research, 6(3), 61-65 .

Shail, M., & Gayatri, A. (2019). Evaluation of pharmacological actions of derivatives of 4-thiazolidiones and 1,3,4- thiadiazoles. European Journal of pharmaceutical and Medical Research, 6(2), 527-538 .